Examl 1:l NRl 293/l NR293l (NEWl 2026/l
2027l Update)l Pharmacologyl forl Nursingl
Practicel Reviewl |l Questionsl &l Answersl |l
Gradel A|l 100%l Correctl (Verifiedl
Solutions)-Chamberlain
QUESTION
Insulinl Typesl &l Action
Answer:
Includesl Rapidl (Lispro),l Shortl (Regular),l Intermediatel (NPH),l Longl (Glargine)l withl
respectivel onset,l peak,l andl duration.
QUESTION
Painl Assessmentl asl al Nurse
Answer:
Subjective:l Whatl thel patientl says;l Objective:l VSl changes,l faciall grimacing,l guarding.
QUESTION
categoryl A
Answer:
studiesl indicatel nol harml tol al humanl fetus
,QUESTION
categoryl b
Answer:
studiesl indicatel nol harml tol animall fetuses,l informationl forl humanl fetusesl isl notl
unavailable
QUESTION
Categoryl C
Answer:
adversel effectsl seenl inl animall fetuses,l nol informationl forl humanl fetusesl available
QUESTION
teratogenicl effect
Answer:
isl al significantl disruptionl inl thel processl ofl embryogenesis
QUESTION
antagonists
Answer:
fitl thel lockl withoutl turningl it,l kickingl outl anyl agonistl keys
, QUESTION
overdose
Answer:
nalaxone
QUESTION
Nalaxone
Answer:
fastl actingl injectablel orl sprayl thatl knocksl fulll andl partiall agonistsl offl thel receptors,l
reversingl respiratoryl depressionl withinl minsl (lessl effectivel againstl fentanyl)
QUESTION
relapsel prevention
Answer:
naltrexone
QUESTION
naltrexone
Answer:
longerl actingl orall tabl orl monthlyl injection,l itl blocksl opioidl effectl sol thatl ifl someonel
relapses,l theyl feell nothingl andl thereforel havel lessl incentivel tol use
2027l Update)l Pharmacologyl forl Nursingl
Practicel Reviewl |l Questionsl &l Answersl |l
Gradel A|l 100%l Correctl (Verifiedl
Solutions)-Chamberlain
QUESTION
Insulinl Typesl &l Action
Answer:
Includesl Rapidl (Lispro),l Shortl (Regular),l Intermediatel (NPH),l Longl (Glargine)l withl
respectivel onset,l peak,l andl duration.
QUESTION
Painl Assessmentl asl al Nurse
Answer:
Subjective:l Whatl thel patientl says;l Objective:l VSl changes,l faciall grimacing,l guarding.
QUESTION
categoryl A
Answer:
studiesl indicatel nol harml tol al humanl fetus
,QUESTION
categoryl b
Answer:
studiesl indicatel nol harml tol animall fetuses,l informationl forl humanl fetusesl isl notl
unavailable
QUESTION
Categoryl C
Answer:
adversel effectsl seenl inl animall fetuses,l nol informationl forl humanl fetusesl available
QUESTION
teratogenicl effect
Answer:
isl al significantl disruptionl inl thel processl ofl embryogenesis
QUESTION
antagonists
Answer:
fitl thel lockl withoutl turningl it,l kickingl outl anyl agonistl keys
, QUESTION
overdose
Answer:
nalaxone
QUESTION
Nalaxone
Answer:
fastl actingl injectablel orl sprayl thatl knocksl fulll andl partiall agonistsl offl thel receptors,l
reversingl respiratoryl depressionl withinl minsl (lessl effectivel againstl fentanyl)
QUESTION
relapsel prevention
Answer:
naltrexone
QUESTION
naltrexone
Answer:
longerl actingl orall tabl orl monthlyl injection,l itl blocksl opioidl effectl sol thatl ifl someonel
relapses,l theyl feell nothingl andl thereforel havel lessl incentivel tol use